The sulfonylureas and glinides targeting the Kir6.2-Sur1 subunits showed an elevated case report number for pancreatic carcinoma and bladder cancers, but a low number of reports for common cancers. Here, KCNJ11 is linked to exocrine pancreatic carcinoma.